CLIENT // Queen Mary University of London
PROJECT // CiTY Centre for Inflammation and Therapeutic Innovation
Located in the heart of the City of London, the new multi-disciplinary Centre for Inflammation and Therapeutic Innovation (CiTI) at Queen Mary University of London (QMUL) presents a unique opportunity for a strategic partnership aimed at exploring, endorsing, developing and testing innovative strategies for anti-inflammatory therapies with a two-way bench to bedside (and backward) approach.
CiTI stems from the world-class track record of the William Harvey Research Institute in inflammation research, bringing together many sections of the School of Medicine and Dentistry, and the College.
The overall aim of this multi-dimensional collaborative venture is to accelerate the application of research discoveries into improved patient care. CiTI will capitalise on QMUL technological expertise and innovations to identify new therapeutic targets, interventions, diagnostics, prevention strategies and stratified medicine in the context of defined inflammatory disorders.